Matthew Johnson's most recent trade in Silicon Laboratories Inc was a trade of 39,282 Common Stock, $0.0001 par value done . Disclosure was reported to the exchange on May 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2025 | 39,282 | 87,192 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 133.17 per share. | 15 May 2025 | 7,625 | 79,567 (0%) | 0% | 133.2 | 1,015,421 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 131.20 per share. | 15 May 2025 | 5,879 | 73,688 (0%) | 0% | 131.2 | 771,325 | Common Stock, $0.0001 par value |
| BKV Corp | Matthew James Johnson | Mng Dir, BKV dCarbon Ventures | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.78 per share. | 02 Jan 2025 | 767 | 203,910 | - | 23.8 | 18,239 | Common Stock |
| BKV Corp | Matthew James Johnson | Mng Dir, BKV dCarbon Ventures | Payment of exercise price or tax liability using portion of securities received from the company at price $ 28.48 per share. | 22 Aug 2024 | 97,017 | 207,855 | - | 28.5 | 2,763,044 | Common Stock |
| BKV Corp | Matthew James Johnson | Mng Dir, BKV dCarbon Ventures | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.00 per share. | 22 Aug 2024 | 9,844 | 198,011 | - | 18 | 177,192 | Common Stock |
| BKV Corp | Matthew James Johnson | Mng Dir, BKV dCarbon Ventures | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Aug 2024 | 6,666 | 204,677 | - | 0 | Common Stock | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 123.80 per share. | 03 Jun 2024 | 7,230 | 47,910 (0%) | 0% | 123.8 | 895,074 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 23,956 | 55,140 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 131.57 per share. | 15 May 2024 | 9,373 | 31,184 (0%) | 0% | 131.6 | 1,233,206 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Johnson Matthew Robert | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2024 | 9,507 | 40,557 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Matthew Robert Johnson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 108.22 per share. | 04 Dec 2023 | 3,679 | 31,050 (0%) | 0% | 108.2 | 398,141 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 144.06 per share. | 02 Aug 2023 | 3,498 | 38,263 (0%) | 0% | 144.1 | 503,922 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 15,992 | 41,761 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 136.32 per share. | 15 May 2023 | 3,537 | 25,769 (0%) | 0% | 136.3 | 482,164 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 188.45 per share. | 15 Feb 2023 | 865 | 29,306 (0%) | 0% | 188.4 | 163,009 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.91 per share. | 31 Jan 2023 | 1,107 | 30,171 (0%) | 0% | 156.9 | 173,699 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 4,405 | 31,278 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 149.38 per share. | 06 Jun 2022 | 5,435 | 26,873 (0%) | 0% | 149.4 | 811,880 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 18,197 | 32,308 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.62 per share. | 13 May 2022 | 1,151 | 14,111 (0%) | 0% | 143.6 | 165,307 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 160.97 per share. | 15 Feb 2022 | 1,709 | 15,262 (0%) | 0% | 161.0 | 275,098 | Common Stock, $0.0001 par value |
| Bakkt Holdings Inc - Ordin... | Matthew Johnson | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 270,422 | 270,422 | - | - | Bakkt Opco Units | |
| Silicon Laboratories Inc | Robert Matthew Johnson | President | Sale of securities on an exchange or to another person at price $ 157.74 per share. | 13 Aug 2021 | 4,829 | 16,971 (0%) | 0% | 157.7 | 761,726 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 158.64 per share. | 13 Aug 2021 | 3,133 | 21,800 (0%) | 0% | 158.6 | 497,019 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2021 | 8,778 | 24,933 (0%) | 0% | 0 | Common Stock, $0.0001 par value | |
| Silicon Laboratories Inc | Robert Matthew Johnson | SR VP & GM, IOT | Sale of securities on an exchange or to another person at price $ 153.19 per share. | 16 Feb 2021 | 3,968 | 16,155 (0%) | 0% | 153.2 | 607,858 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | SR VP & GM, IOT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 154.34 per share. | 12 Feb 2021 | 1,399 | 20,123 (0%) | 0% | 154.3 | 215,922 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | SR VP & GM, IOT | Sale of securities on an exchange or to another person at price $ 100.12 per share. | 14 Aug 2020 | 5,692 | 21,522 (0%) | 0% | 100.1 | 569,883 | Common Stock, $0.0001 par value |
| Silicon Laboratories Inc | Robert Matthew Johnson | SR VP & GM, IOT | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.57 per share. | 14 Aug 2020 | 2,269 | 27,214 (0%) | 0% | 100.6 | 228,193 | Common Stock, $0.0001 par value |